Metastatic Prostate Cancer
Showing 9951 - 9975 of >10,000
Endocrine Disrupting Chemicals, Health Literacy Trial in Taipei (Experimental: nursing education interventions (including
Recruiting
- Endocrine Disrupting Chemicals
- Health Literacy
- Experimental: nursing education interventions (including e-health platform assistance)
-
Taipei, Taipei City, TaiwanCheng Hsin General Hospital
Feb 17, 2022
Stress, Cancer Diagnosis, Distress, Emotional Trial in Boston (Smart-3RP, Enhanced Usual Care)
Not yet recruiting
- Stress
- +2 more
- Smart-3RP
- Enhanced Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 18, 2023
Lung Tumor Malignant, Mesothelioma; Lung Trial in Hull, York (Tailored nutrition and physical activity programme)
Recruiting
- Lung Neoplasm Malignant
- Mesothelioma; Lung
- Tailored nutrition and physical activity programme
-
Hull, Yorkshire, United Kingdom
- +1 more
Jun 23, 2022
Anlotinib Combined With Chemotherapy for Treatment of HER2
Not yet recruiting
- HER2-negative Breast Cancer
- (no location specified)
Apr 18, 2022
Triple-negative Breast Cancer Trial in Shanghai (choline, anti-PD-1 antibody and chemo, Sodium Cromoglicate)
Recruiting
- Triple-negative Breast Cancer
- Choline
- +3 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 29, 2022
Prostate Cancer Trial (Prostate Cancer Comorbidity Index (PCCI) score)
Completed
- Prostate Cancer
- Prostate Cancer Comorbidity Index (PCCI) score
- (no location specified)
Jun 10, 2019
Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8 Trial in United States (drug, biological, other, radiation)
Recruiting
- Bladder Urothelial Carcinoma
- Stage III Bladder Cancer AJCC v8
- Cisplatin
- +6 more
-
Anchorage, Alaska
- +212 more
Jan 31, 2023
Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)
Completed
- Renal Cell Carcinoma
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- +2 more
-
Tucson, Arizona
- +153 more
Jan 13, 2022
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +66 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +76 more
Jan 11, 2023
Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Canada, United
Completed
- Endometrial Adenocarcinoma
- +7 more
- Sunitinib Malate
-
Beverly Hills, California
- +28 more
Feb 14, 2020
Head Neck Cancer, Lung Cancer, Prostate Cancer Trial in Miami (CT Scan)
Completed
- Head and Neck Cancer
- +2 more
- CT Scan
-
Miami, FloridaUniversity of Miami
Jan 21, 2020
Ovarian Tumors Trial in Chongqing
Recruiting
- Ovarian Neoplasms
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 12, 2022
Rectal Tumors Trial (procedure, drug, diagnostic test)
Not yet recruiting
- Rectal Neoplasms
- Arterial chemoembolization
- +4 more
- (no location specified)
Jun 26, 2022
Colorectal Carcinoma Trial in Austria (endurance exercise, control)
Recruiting
- Colorectal Carcinoma
- endurance exercise
- control
-
Graz, Styria, Austria
- +8 more
May 24, 2022
BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in
Recruiting
- BCLC Stage A Hepatocellular Carcinoma
- +3 more
- 18F-Fluoromisonidazole
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
May 25, 2022
Lung Cancer Trial in Decatur ((99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose), 18 F FDG followed by PET/CT imaging)
Active, not recruiting
- Lung Cancer
- (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose)
- 18 F FDG followed by PET/CT imaging
-
Decatur, IllinoisDecatur Memorial Hospital
Jan 28, 2021
Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases Trial in Aurora (Ranolazine)
Completed
- Adenocarcinoma of the Prostate
- +6 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Nov 29, 2018
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Recruiting
- Non-small Cell Lung Cancer
-
Harlow, Essex, United Kingdom
- +17 more
Feb 22, 2022
Cellular Immunity and Renal Cell Cancer
Completed
- NK Cell Mediated Immunity
- +2 more
-
Rijeka, CroatiaClinical Hospital Center Rijeka
Sep 19, 2021
Biochemical Relapse After Radical Prostatectomy for Prostate
Completed
- Prostatic Adenocarcinoma
-
Brest, Bretagne, France
- +1 more
Sep 11, 2019
Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC
Not yet recruiting
- Stage IB Hepatocellular Carcinoma AJCC v8
- +2 more
- Durvalumab
- Regorafenib
-
Gainesville, Florida
- +3 more
Jun 15, 2022
Taxane Acute Pain Syndrome in Patients Receiving Taxane
Completed
- Acute Pain
- Quality of life and brief pain inventory
-
Ottawa, Ontario, CanadaRicardo Fernandes
Sep 3, 2019
Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)
Recruiting
- Colonic Neoplasms
- Colorectal Neoplasms
- GRT-C901
- +4 more
-
Detroit, Michigan
- +2 more
Aug 1, 2022
Cancer Metastatic Trial in Hillsboro (Single-Fraction Palliative Radiation Therapy)
Unknown status
- Cancer Metastatic
- Single-Fraction Palliative Radiation Therapy
-
Hillsboro, OregonCarePartners
Jan 21, 2020